Wilmington Savings Fund Society FSB cut its stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 15.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,261 shares of the company’s stock after selling 235 shares during the period. Wilmington Savings Fund Society FSB’s holdings in Henry Schein were worth $87,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in HSIC. Sumitomo Mitsui DS Asset Management Company Ltd increased its position in shares of Henry Schein by 3.8% during the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,491 shares of the company’s stock worth $934,000 after buying an additional 497 shares during the period. GHP Investment Advisors Inc. boosted its position in Henry Schein by 2.2% during the fourth quarter. GHP Investment Advisors Inc. now owns 55,739 shares of the company’s stock valued at $3,857,000 after acquiring an additional 1,176 shares during the last quarter. Private Management Group Inc. grew its holdings in Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after acquiring an additional 18,882 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Henry Schein by 29.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company’s stock worth $1,113,000 after acquiring an additional 3,650 shares in the last quarter. Finally, Mather Group LLC. lifted its stake in shares of Henry Schein by 43.7% in the 4th quarter. Mather Group LLC. now owns 1,503 shares of the company’s stock valued at $104,000 after purchasing an additional 457 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.
Insider Transactions at Henry Schein
In other news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 1.14% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Analysis on Henry Schein
Henry Schein Price Performance
Shares of NASDAQ HSIC opened at $77.62 on Friday. The stock has a market cap of $9.68 billion, a price-to-earnings ratio of 31.94, a PEG ratio of 2.21 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The firm’s 50-day simple moving average is $73.85 and its 200 day simple moving average is $71.93.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories
- Five stocks we like better than Henry Schein
- What Investors Need to Know About Upcoming IPOs
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- How to Use the MarketBeat Stock Screener
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- How to Capture the Benefits of Dividend Increases
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.